Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

A LoGiCal® Success at Analytical Services International

Published: Friday, April 20, 2012
Last Updated: Friday, April 20, 2012
Bookmark and Share
New product range from LGC Standards for therapeutic drug monitoring services.

Analytical Services International (ASI) at St George’s, University of London, UK, has been evaluating LoGiCal certified reference materials - a new product range from LGC Standards - for its therapeutic drug monitoring (TDM) services, where high quality reference standards are an essential requirement.

The use of high quality reference materials is equally important for the Company’s international proficiency testing scheme for immunosuppressive drugs, co-ordinated by Professor David Holt.

ASI recently validated the use of LoGiCal solutions of the immunosuppressant mycophenolic acid (MPA) and antiarrhythmic amiodarone metabolite desethylamiodarone (DEA) in its assays.

Michelle Moreton-Clack, TDM Service Manager, explained: “As part of our therapeutic drug monitoring service, we run assays for the measurement of MPA and DEA. We usually buy the drugs in powder form and weigh them out to prepare stock solutions for our assays. The LoGiCal range includes ISO Guide 34 certified solutions of MPA and DEA, which are really easy to use and save a lot of time by eliminating weighing stages. We validated both compounds against our existing stock solutions, and they showed good correlation; I am very pleased with the results.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LGC Standards Partners with PRIMACYT to Improve Access to Hepatocytes for Drug Discovery Research
The partnership will facilitate a wider distribution of hepatocyte cells and allow greater access to these important in-vitro models.
Sunday, February 20, 2011
New Reference Materials Sourced to Meet the Needs of the World's Leading Toxicologists
Testing for ‘designer drugs’, ‘legal highs’ and other novel materials is a continuing challenge for clinical, forensic, sports testing and toxicology laboratories.
Tuesday, October 07, 2008
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos